Fatigue

• 

  Subject Areas on Research

  • 74-Year-Old Woman With Fatigue, Anorexia, and Abdominal Pain. 
  • A Collaborative Paradigm for Improving Management of Sleep Disorders in Primary Care: A Randomized Clinical Trial. 
  • A National Study of Zoom Fatigue and Mental Health During the COVID-19 Pandemic: Implications for Future Remote Work. 
  • A comparison of stapedial reflex fatigue with repetitive stimulation and single-fiber EMG in myasthenia gravis. 
  • A distribution-free test of constant mean in linear mixed effects models. 
  • A feasible and acceptable multicultural psychosocial intervention targeting symptom management in the context of advanced breast cancer. 
  • A longitudinal evaluation of fatigue in chronic inflammatory demyelinating polyneuropathy. 
  • A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer. 
  • A phase 1 trial of SGN-CD70A in patients with CD70-positive, metastatic renal cell carcinoma. 
  • A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors. 
  • A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer. 
  • A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: a Southwest oncology group (SWOG 9924) study. 
  • ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. 
  • Acute Presentation of Previously Unrecognized Congenital Ureteropelvic Junction Obstruction 5 Weeks After Radical Retropubic Prostatectomy. 
  • Advancing Symptom Science Through Use of Common Data Elements. 
  • Advancing the science of mind-body interventions: a comment on Larkey et al. 
  • Angiotensin-converting enzyme genotype predicts cardiac and autonomic responses to prolonged exercise. 
  • Anti-hypotensive treatment and endothelin blockade synergistically antagonize exercise fatigue in rats under simulated high altitude. 
  • Anticholinergic Drug Burden in Noncancer Versus Cancer Patients Near the End of Life. 
  • Arrhythmias in children having a single left superior vena cava and minimal structural heart disease. 
  • Association between fatigue and sleep disturbances during treatment for pediatric acute lymphoblastic leukemia and posttreatment neurocognitive performance. 
  • Association of Nondisease-Specific Problems with Mortality, Long-Term Care, and Functional Impairment among Older Adults Who Require Skilled Nursing Care after Dialysis Initiation. 
  • Association of consistently suboptimal quality of life with consistently poor asthma control in children with asthma. 
  • Benefits and promotion of physical activity in rheumatoid arthritis. 
  • Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022). 
  • Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results. 
  • Binaural auditory beats affect vigilance performance and mood. 
  • Biomarkers as Common Data Elements for Symptom and Self-Management Science. 
  • Boredom in the Workplace: A New Look at an Old Problem. 
  • Brain and central haemodynamics and oxygenation during maximal exercise in humans. 
  • Breaking the vicious circle of fatigue in patients with chronic heart failure. 
  • Brief Behavioral Therapy and Bupropion for Sleep and Fatigue in Young Adults With Crohn's Disease: An Exploratory Open Trial Study. 
  • COPD-Related Fatigue: A Scoping Review. 
  • Can Steps per Day Reflect Symptoms in Children and Adolescents Undergoing Cancer Treatment? 
  • Cancer-Related Fatigue, Version 2.2015. 
  • Cancer-related fatigue. 
  • Cancer-related fatigue: scientific progress has been made in 40 years 
  • Cancer-related loneliness mediates the relationships between social constraints and symptoms among cancer patients. 
  • Cardiac fatigue after prolonged exercise. 
  • Carnitine plasma levels and fatigue in children/adolescents receiving cisplatin, ifosfamide, or doxorubicin. 
  • Central pain contributions in osteoarthritis: next steps for improving recognition and treatment? 
  • Cerebrospinal Fluid Metabolomic Profiles Associated With Fatigue During Treatment for Pediatric Acute Lymphoblastic Leukemia. 
  • Changes in patient-reported outcomes in light chain amyloidosis in the first year after diagnosis and relationship to NT-proBNP change. 
  • Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. 
  • Chronicity and remission of fatigue in patients with established HIV infection. 
  • Cigarette smoking during anxiety-provoking and monotonous tasks. 
  • Clinical Decision Support for Symptom Management in Lung Cancer Patients: A Group RCT. 
  • Clinical features of depression in Asia: results of a large prospective, cross-sectional study. 
  • Clinical field testing of an enhanced-activity intervention in hospitalized children with cancer. 
  • Clinical outcomes of patients with advanced gastrointestinal stromal tumors: safety and efficacy in a worldwide treatment-use trial of sunitinib. 
  • Clinical problem-solving. A hole in the argument. 
  • Clinico-pathologic conference: 12-year-old girl with fatigue, anemia, weight loss, abdominal distention, and occasional nausea and vomiting. 
  • Co-occurring Fatigue and Lymphatic Pain Incrementally Aggravate Their Negative Effects on Activities of Daily Living, Emotional Distress, and Overall Health of Breast Cancer Patients. 
  • Cognitive behavioral therapy for chronic pain is effective, but for whom? 
  • Cognitive problems following hematopoietic stem cell transplant: relationships with sleep, depression and fatigue. 
  • Comparing patient, parent, and staff descriptions of fatigue in pediatric oncology patients. 
  • Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer. 
  • Complementary/integrative healthcare utilization in US Gulf-War era veterans: Descriptive analyses based on deployment history, combat exposure, and Gulf War Illness. 
  • Composite measures of physical activity and pain associate better with functional assessments than pain alone in knee osteoarthritis. 
  • Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients. 
  • Conducting research in psoriatic arthritis: the emerging role of patient research partners. 
  • Conflict and emotional exhaustion in obstetrician-gynaecologists: a national survey. 
  • Construct validity of Patient-Reported Outcomes Measurement Information System Paediatric measures in juvenile idiopathic arthritis and systemic lupus erythematosus: cross-sectional evaluation. 
  • Contribution of cancer symptoms, dysfunctional sleep related thoughts, and sleep inhibitory behaviors to the insomnia process in breast cancer survivors: a daily process analysis. 
  • Correlates of fatigue in older adults with rheumatoid arthritis. 
  • Couples and breast cancer: women's mood and partners' marital satisfaction predicting support perception. 
  • Creating computable algorithms for symptom management in an outpatient thoracic oncology setting. 
  • Cumulative deficits better characterize susceptibility to death in elderly people than phenotypic frailty: lessons from the Cardiovascular Health Study. 
  • Daily pain and symptoms in children with polyarticular arthritis. 
  • Daytime sleepiness, nighttime sleep quality, stressful life events, and HIV-related fatigue. 
  • Demographic and illness-related variables associated with HIV-related fatigue. 
  • Demographic differences in health preferences in the United States. 
  • Deriving clinically meaningful cut-scores for fatigue in a cohort of breast cancer survivors: a Health, Eating, Activity, and Lifestyle (HEAL) Study. 
  • Determining Resident Sleep During and After Call With Commercial Sleep Monitoring Devices. 
  • Developing a research program on fatigue in children and adolescents diagnosed with cancer. 
  • Development and Initial Validation of a Systemic Lupus Erythematosus-Specific Measure of the Extent of and Reasons for Medication Nonadherence. 
  • Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia. 
  • Differences between patients with cardiovascular disease and cancer referred for palliative care. 
  • Differences in effectiveness of the active living every day program for older adults with arthritis. 
  • Distinct Sleep Disturbance Profiles in Patients With Gastrointestinal Cancers Receiving Chemotherapy. 
  • Distress persists in long-term brain tumor survivors with glioblastoma multiforme. 
  • Distribution of distress in post-socialist Mongolia: a cultural epidemiology of yadargaa. 
  • Diurnal cortisol rhythm as a predictor of lung cancer survival. 
  • Do estrogen or selective estrogen receptor modulators improve quality of life for women with postmenopausal osteoporosis? 
  • Double-Blind, Placebo-Controlled, Crossover Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia. 
  • Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study. 
  • Duty-hour exceptions for neurosurgery residency programs. 
  • Eculizumab improves fatigue in refractory generalized myasthenia gravis. 
  • Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial. 
  • Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy. 
  • Effects of S-nitroso- N-acetylcysteine on contractile function of reperfused skeletal muscle. 
  • Effects of brief caffeinated-beverage deprivation on mood, symptoms, and psychomotor performance. 
  • Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks. 
  • Efficacy and Safety of Pembrolizumab in Patients Enrolled in KEYNOTE-030 in the United States: An Expanded Access Program. 
  • Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation. 
  • Energetic and endurance constraints on great ape quadrupedalism and the benefits of hominin bipedalism. 
  • Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. 
  • Estimating minimally important difference (MID) in PROMIS pediatric measures using the scale-judgment method. 
  • Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. 
  • Evaluation of Novel Metrics of Symptom Relief in Acute Heart Failure: The Worst Symptom Score. 
  • Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19). 
  • Evolving symptom networks in relation to HIV-positive duration among people living with HIV: A network analysis. 
  • Executive control, ERP and pro-inflammatory activity in emotionally exhausted middle-aged employees. Comparison between subclinical burnout and mild to moderate depression. 
  • Exercise and dietary change after diagnosis and cancer-related symptoms in long-term survivors of breast cancer: CALGB 79804. 
  • Exercise as treatment for androgen deprivation therapy-associated physical dysfunction: ready for prime time? 
  • Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: findings from a randomized, double-blind, placebo-controlled study. 
  • Fatigue alters lower extremity kinematics during a single-leg stop-jump task. 
  • Fatigue and Oxidative Stress in Children Undergoing Leukemia Treatment. 
  • Fatigue and carnitine levels over multiple cycles of chemotherapy in children and adolescents. 
  • Fatigue and fluid hydration status in multiple sclerosis: A hypothesis. 
  • Fatigue and recovery in 12-hour dayshift hospital nurses. 
  • Fatigue and sleep disorders. 
  • Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion. 
  • Fatigue in 7- to 12-year-old patients with cancer from the staff perspective: an exploratory study. 
  • Fatigue in Children With Sickle Cell Disease: Association With Neurocognitive and Social-Emotional Functioning and Quality of Life. 
  • Fatigue in HIV-Infected People: A Three-Year Observational Study. 
  • Fatigue in Nondialysis Chronic Kidney Disease: Correlates and Association with Kidney Outcomes. 
  • Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN). 
  • Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report. 
  • Fatigue in children and adolescents with cancer. 
  • Fatigue in children and adolescents with cancer: evolution of a program of study. 
  • Fatigue in chronic inflammatory demyelinating polyneuropathy. 
  • Fatigue in older cancer patients: etiology, assessment, and treatment. 
  • Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. 
  • Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donors. 
  • Frailty and health-related quality of life in older women with breast cancer. 
  • Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer. 
  • Greater mindfulness associated with lower pain, fatigue, and psychological distress in women with metastatic breast cancer. 
  • Helical tomotherapy for bilateral breast cancer: Clinical experience. 
  • Higher symptom burden is associated with lower function in women taking adjuvant endocrine therapy for breast cancer. 
  • Hope in the context of lung cancer: relationships of hope to symptoms and psychological distress. 
  • How changes in physical activity relate to fatigue interference, mood, and quality of life during treatment for non-metastatic breast cancer. 
  • Hypothyroidism in house officers. 
  • I look funny and I feel bad. Measurement of symptom distress. 
  • Identifying Symptom Clusters Among People Living With HIV on Antiretroviral Therapy in China: A Network Analysis. 
  • Imaging-Guided Core-Needle Breast Biopsy: Impact of Meditation and Music Interventions on Patient Anxiety, Pain, and Fatigue. 
  • Impact of Low Carbohydrate Diet on Self-Report Fatigue and Weakness in Prostate Cancer Patients. 
  • Impact of Personal Protective Equipment on Pediatric Cardiopulmonary Resuscitation Performance: A Controlled Trial. 
  • Impact of enzalutamide on patient-reported fatigue in patients with prostate cancer: data from the pivotal clinical trials. 
  • Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients. 
  • Improvements in Depression and Changes in Fatigue: Results from the SLAM DUNC Depression Treatment Trial. 
  • Indirect Comparison of Darolutamide versus Apalutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer. 
  • Individual differences in the day-to-day variability of pain, fatigue, and well-being in patients with rheumatic disease: associations with psychological variables. 
  • Influence of Inflammatory and Oxidative Stress Pathways on Longitudinal Symptom Experiences in Children With Leukemia. 
  • Influence of Nitrosative Stress on Fatigue During Childhood Leukemia Treatment. 
  • Inspiratory muscle strength and endurance during hyperinflation and histamine induced bronchoconstriction. 
  • Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials. 
  • Integrative Medicine Patients Have High Stress, Pain, and Psychological Symptoms. 
  • Intensity, chronicity, circumstances, and consequences of HIV-related fatigue: a longitudinal study. 
  • International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. 
  • Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study. 
  • Is Traditional Chinese Medicine Use Associated with Worse Patient-reported Outcomes among Chinese American Rheumatology Patients? 
  • Is there an association between Health Related Quality of Life, socio-demographic status and Fatigue in Patients with Chronic Hepatitis B? 
  • Is this patient clinically depressed? 
  • Long-term issues in the treatment of sleep disorders. 
  • Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial. 
  • Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trial. 
  • Longitudinal use of patient reported outcomes in pediatric leukemia and lymphoma reveals clinically relevant symptomatic adverse events. 
  • Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study-CALGB 30607 (Alliance). 
  • Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. 
  • Measurement of fatigue in systemic lupus erythematosus: a systematic review. 
  • Measuring fatigue in people living with HIV/AIDS: psychometric characteristics of the HIV-related fatigue scale. 
  • Mechanisms of dexamethasone-induced disturbed sleep and fatigue in paediatric patients receiving treatment for ALL. 
  • Mifepristone (RU 486) for Alzheimer's disease. 
  • Milnacipran: beyond a role of antidepressant. 
  • Mindful Yoga for women with metastatic breast cancer: design of a randomized controlled trial. 
  • Molecular endotypes of type 1 and type 2 SLE. 
  • Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. 
  • Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. 
  • Multidimensional Fatigue Inventory in People With Hepatitis B Infection: Cross-cultural Adaptation and Psychometric Evaluation of the Persian Version. 
  • Multidimensional success criteria and expectations for treatment of chronic pain: the patient perspective. 
  • Muscle dysfunction associated with chronic obstructive pulmonary disease. 
  • Nausea, pain, fatigue, and multiple symptoms in hospitalized children with cancer. 
  • Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial. 
  • Nocturnal awakenings, sleep environment interruptions, and fatigue in hospitalized children with cancer. 
  • Novel marine-derived anticancer agents: a phase I clinical, pharmacological, and pharmacodynamic study of dolastatin 10 (NSC 376128) in patients with advanced solid tumors. 
  • One size does not fit all-mobility device type affects speed, collisions, fatigue, and pain. 
  • PROMIS Fatigue Item Bank had Clinical Validity across Diverse Chronic Conditions. 
  • PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions. 
  • PROMIS® Adult Health Profiles: Efficient Short-Form Measures of Seven Health Domains. 
  • Pain, stiffness, and fatigue in juvenile polyarticular arthritis: contemporaneous stressful events and mood as predictors. 
  • Patient and Caregiver Attitudes and Practices of Exercise in Candidates Listed for Liver Transplantation. 
  • Patient preferences in advanced or recurrent ovarian cancer. 
  • Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. 
  • Patient-Reported Outcomes after Laparoscopic Ventral Hernia Repair. 
  • Patient-defined desired outcome, success criteria, and expectation in outpatient physical therapy: a longitudinal assessment. 
  • Patient-reported outcomes in sickle cell disease and association with clinical and psychosocial factors: Report from the sickle cell disease implementation consortium. 
  • Patients with chronic hepatitis C undergoing watchful waiting: Exploring trajectories of illness uncertainty and fatigue. 
  • Patients, caregivers, and clinicians differ in performance status ratings: Implications for pediatric cancer clinical trials. 
  • Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation. 
  • Perceived Stress in Patients with Common Gastrointestinal Disorders: Associations with Quality of Life, Symptoms and Disease Management. 
  • Perceptions of Exercise and Its Challenges in Patients With Nonalcoholic Fatty Liver Disease: A Survey-Based Study. 
  • Persistent Rash in a Patient Receiving Total Parenteral Nutrition. 
  • Persistent fatigue among long-term non-Hodgkin lymphoma survivors. 
  • Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas. 
  • Phase 1 trial of ibrutinib and carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma. 
  • Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection. 
  • Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma. 
  • Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. 
  • Phase I trial of pazopanib in patients with advanced cancer. 
  • Phase II study of (90)Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma. 
  • Physical Activity, the Childhood Cancer Symptom Cluster-Leukemia, and Cognitive Function: A Longitudinal Mediation Analysis. 
  • Physical activity, long-term symptoms, and physical health-related quality of life among breast cancer survivors: a prospective analysis. 
  • Physical function in men and women with cancer. Effects of anemia and conditioning. 
  • Physiological and psychosocial factors that predict HIV-related fatigue. 
  • Physiological basis of fatigue. 
  • Physiological correlates of HIV-related fatigue. 
  • Post-operative smoking status in lung and head and neck cancer patients: association with depressive symptomatology, pain, and fatigue. 
  • Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420. 
  • Predictors and patterns of participant adherence to a cortisol collection protocol. 
  • Predictors of depression recovery in HIV-infected individuals managed through measurement-based care in infectious disease clinics. 
  • Preliminary efficacy of a lovingkindness meditation intervention for patients undergoing biopsy and breast cancer surgery: A randomized controlled pilot study. 
  • Preliminary results of patient-defined success criteria for individuals with musculoskeletal pain in outpatient physical therapy settings. 
  • Profile of cancer-related symptoms prior to chemotherapy. 
  • Promoting physical activity in childhood cancer survivors: results from the Childhood Cancer Survivor Study. 
  • Psychometric and clinical assessment of the 10-item reduced version of the Fatigue Scale-Child instrument. 
  • Psychometric and clinical assessment of the 13-item reduced version of the fatigue scale-adolescent instrument. 
  • Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorder. 
  • Psychosocial factors and the pain experience of osteoarthritis patients: new findings and new directions. 
  • Quantitative assessment of cardiorespiratory fitness, skeletal muscle function, and body composition in adults with primary malignant glioma. 
  • Recommendations for high-priority research on cancer-related fatigue in children and adults. 
  • Recommended patient-reported core set of symptoms and quality-of-life domains to measure in ovarian cancer treatment trials. 
  • Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. 
  • Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials. 
  • Reconsidering Physical Activity Restrictions for Mononephric Survivors of Childhood Cancer: A Report From the Children's Oncology Group. 
  • Reimagine: a randomized controlled trial of an online, symptom self-management curriculum among breast cancer survivors. 
  • Reinforcement and Fatigue of a Bioinspired Mineral-Organic Bioresorbable Bone Adhesive. 
  • Relationship between social support, physical symptoms, and depression in women with breast cancer and pain. 
  • Reliability and construct validity of PROMIS® measures for patients with heart failure who undergo heart transplant. 
  • Remotely engaged: Lessons from remote monitoring in multiple sclerosis. 
  • Residual symptoms following empirically supported treatment for PTSD. 
  • Resistance to thyroid hormone in a patient without thyroid hormone receptor mutations. 
  • Responsiveness of the PROMIS® measures to changes in disease status among pediatric nephrotic syndrome patients: a Midwest pediatric nephrology consortium study. 
  • Responsiveness of the Patient-reported Outcomes Measurement Information System (PROMIS) Pediatric Measures to Changes in Disease Status and Quality of Life Among Children and Adolescents With Crohn's Disease. 
  • Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer: a phase 1b study. 
  • Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North America. 
  • Self reported morbidity and awareness regarding common cancers in elderly women. 
  • Self-Reported Health Outcomes of Children and Youth with 10 Chronic Diseases. 
  • Self-efficacy and pain catastrophizing in systemic lupus erythematosus: relationship to pain, stiffness, fatigue, and psychological distress. 
  • Self-efficacy for managing pain, symptoms, and function in patients with lung cancer and their informal caregivers: associations with symptoms and distress. 
  • Self-reported pain and disease symptoms persist in juvenile idiopathic arthritis despite treatment advances: an electronic diary study. 
  • Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study. 
  • Sexual concerns in lung cancer patients: an examination of predictors and moderating effects of age and gender. 
  • Sexual functioning of men and women with severe obesity before bariatric surgery. 
  • Short-term improvement in insomnia symptoms predicts long-term improvements in sleep, pain, and fatigue in older adults with comorbid osteoarthritis and insomnia. 
  • Sickness behavior clustering in children with cancer. 
  • Sleep and fatigue in mice infected with murine gammaherpesvirus 68. 
  • Sleep patterns of sheltered battered women 
  • Sleep quality in individuals diagnosed with colorectal cancer: Factors associated with sleep disturbance as patients transition off treatment. 
  • Sleep satisfaction and cognitive complaints in Chinese middle-aged and older persons living with HIV: the mediating role of anxiety and fatigue. 
  • Social Support Moderates the Relationship Between Perceived Stress and Quality of Life in Patients With a Left Ventricular Assist Device. 
  • Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus. 
  • Somnolence syndrome after focal radiation therapy to the pineal region: case report and review of the literature. 
  • Sources of work-related acute fatigue in United States hospital nurses. 
  • Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma. 
  • Study design and methods for the pilot study of muscadine grape extract supplement to improve fatigue among older adult cancer survivors (FOCUS) trial. 
  • Sustainable and equivalent improvements in symptoms and functional well-being following viral cure from ledipasvir/sofosbuvir versus elbasvir/grazoprevir for chronic hepatitis C infection: Findings from the randomized PRIORITIZE trial. 
  • Symptom Burden and Performance Status among Community-Dwelling Patients with Serious Illness. 
  • Symptom Clusters, Physical Activity, and Quality of Life: A Latent Class Analysis of Children During Maintenance Therapy for Leukemia. 
  • Symptom Distress: Implementation of Palliative Care Guidelines to Improve Pain, Fatigue, and Anxiety in Patients With Advanced Cancer. 
  • Symptom Science: Advocating for Inclusion of Functional Genetic Polymorphisms. 
  • Symptom and function profiles of men with localized prostate cancer. 
  • Symptom challenges after atrial fibrillation ablation. 
  • Symptom clusters in children and adolescents receiving cisplatin, doxorubicin, or ifosfamide. 
  • Symptom clusters in children with cancer. 
  • Symptom clusters in children. 
  • Symptom experiences of children and adolescents with cancer. 
  • Symptom management in the elderly cancer patient: fatigue, pain, and depression. 
  • Symptom management research in children with cancer. 
  • Symptoms and functioning improve after chronic hepatitis C cure as assessed by the Memorial Symptom Assessment Scale and PROMIS measures. 
  • Systemic reactions to imiquimod (Aldara). 
  • Tailoring nutrition therapy to illness and recovery. 
  • Testicular cancer survivorship: research strategies and recommendations. 
  • Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET). 
  • Testing an instrument to screen for fibromyalgia syndrome in general population studies: the London Fibromyalgia Epidemiology Study Screening Questionnaire. 
  • The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative. 
  • The Association Between Toxic Exposures and Chronic Multisymptom Illness in Veterans of the Wars of Iraq and Afghanistan. 
  • The BraveNet prospective observational study on integrative medicine treatment approaches for pain. 
  • The Burden of Congestion in Patients Hospitalized With Acute Decompensated Heart Failure. 
  • The Categorization of Pain in Systemic Lupus Erythematosus. 
  • The Effect of Thiazide and Potassium Citrate Use on the Health Related Quality of Life of Patients with Urolithiasis. 
  • The Effects of Exercise on Patient-Reported Outcomes and Performance-Based Physical Function in Adults With Acute Leukemia Undergoing Induction Therapy: Exercise and Quality of Life in Acute Leukemia (EQUAL). 
  • The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates. 
  • The Longitudinal Parallel Process Analysis of Biomarkers of Oxidative Stress, Symptom Clusters, and Cognitive Function in Children With Leukemia. 
  • The Piper Fatigue Scale-12 (PFS-12): psychometric findings and item reduction in a cohort of breast cancer survivors. 
  • The Prospective Evaluation of the Net Effect of Red Blood Cell Transfusions in Routine Provision of Palliative Care. 
  • The Symptom Experience in Rectal Cancer Survivors. 
  • The Valjean effect: Visceral states and cheating. 
  • The association of comorbid conditions with patient-reported outcomes in Veterans with hip and knee osteoarthritis. 
  • The association of fatigue with depression and insomnia in HIV-seropositive patients: a pilot study. 
  • The challenge of measuring intra-individual change in fatigue during cancer treatment. 
  • The double-blind in danger: untoward consequences of informed consent. 
  • The experience and self-management of fatigue in patients on hemodialysis. 
  • The influence of adjuvant therapy on cardiorespiratory fitness in early-stage breast cancer seven years after diagnosis: the Cooper Center Longitudinal Study. 
  • The influence of oxidative stress on symptom occurrence, severity, and distress during childhood leukemia treatment. 
  • The ischemic exercise test in normal adults and in patients with weakness and cramps. 
  • The patient perspective on absence of disease activity in rheumatoid arthritis: a survey to identify key domains of patient-perceived remission. 
  • The perspective of the vascular surgery trainee on new ACGME regulations, fatigue, resident training, and patient safety. 
  • The relationship between adverse events during selective serotonin reuptake inhibitor treatment for major depressive disorder and nonremission in the suicide assessment methodology study. 
  • The role of symptoms and self-efficacy in predicting physical activity change among older adults with arthritis. 
  • The use of PROMIS patient-reported outcomes (PROs) to inform light chain (AL) amyloid disease severity at diagnosis. 
  • The worst symptom as defined by patients during heart failure hospitalization: implications for response to therapy. 
  • Therapy with bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma: final results of a phase II trial (CALGB 50501). 
  • Three instruments to assess fatigue in children with cancer: the child, parent and staff perspectives. 
  • Time of day effects on the incidence of anesthetic adverse events. 
  • Tonight's Sleep Predicts Tomorrow's Fatigue: A Daily Diary Study of Long-Term Care Employees With Nonwork Caregiving Roles. 
  • Trajectories of fatigue in a population-based sample of older adult breast, prostate, and colorectal cancer survivors: an analysis using the SEER-MHOS data resource. 
  • Transportation: a vehicle or roadblock to cancer care for VA patients with colorectal cancer? 
  • Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study. 
  • Trauma, stressful life events and depression predict HIV-related fatigue. 
  • Triggers and alleviating factors for fatigue in Parkinson's disease. 
  • Triggers of uncertainty about recurrence and long-term treatment side effects in older African American and Caucasian breast cancer survivors. 
  • Two Methods for Calculating Symptom Cluster Scores. 
  • Two open whipples a day: Excessive or efficient. 
  • US valuation of health outcomes measured using the PROMIS-29. 
  • Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study. 
  • Uncertainty, symptoms, and quality of life in persons with chronic hepatitis C. 
  • Understanding the Lexicon of Fatigue in Parkinson's Disease. 
  • Understanding what matters to metastatic castration-resistant prostate cancer (mCRPC) patients when considering treatment options: A US patient preference survey. 
  • Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients. 
  • Validation of the Patient Care Monitor (Version 2.0): a review of system assessment instrument for cancer patients. 
  • Validation of the caregiver Pediatric Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events measure. 
  • Validity and reliability of a new instrument to measure cancer-related fatigue in adolescents. 
  • Ventilatory muscle loads and the frequency-tidal volume pattern during inspiratory pressure-assisted (pressure-supported) ventilation. 
  • Virtual reality as a distraction intervention for women receiving chemotherapy. 
  • Vital exhaustion and retinal microvascular changes in cardiovascular disease: atherosclerosis risk in communities study. 
  • Weaning from mechanical ventilation. 
  • Weight Loss, Diabetes, Fatigue, and Depression Preceding Pancreatic Cancer. 
  • What do these scores mean? Presenting patient-reported outcomes data to patients and clinicians to improve interpretability. 
  • Work-Related Determinants of Burnout in a Nationally Representative Sample of German Employees: Results From the Study on Mental Health at Work. 
  • Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809. 
  • rHuEPO and improved treatment outcomes: potential modes of action. 
• 

  Keywords of People

  • Allen, Kelli Dominick, Adjunct Professor in the Department of Medicine, Medicine, General Internal Medicine
  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Hall, Katherine Shepherd, Associate Professor in Medicine, Medicine, Geriatrics
  • Reuter Rice, Karin Eve, Associate Professor in the School of Nursing, School of Nursing
  • Zafar, Syed Yousuf, Adjunct Professor in the Department of Medicine, Duke Science & Society